| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00029 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.00019 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.00025 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.00019 | 1 |